Czechia, April 27 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - Selective Immunosuppressants - Vedolizumab VII. The value of the contract is worth 10055088200 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....